The long-term outcome of anti-tumor necrosis factor-α therapy related to fecal calprotectin values during induction therapy in pediatric inflammatory bowel disease

Author： Kolho Kaija-Leena   Sipponen Taina  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.49, Iss.4, 2014-04, pp. : 434-441

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Treatment of Dermatomyositis and Polymyositis with Anti-Tumor Necrosis Factor-α: Long-Term Follow-Up

By  

European Neurology, Vol. 52, Iss. 1, 2004-07 ,pp. : 61-63

Karger

Access to resources Recommend Favorite

Fecal calprotectin remains high during glucocorticoid therapy in children with inflammatory bowel disease

By Kolho Kaija-Leena   Raivio Taneli   Lindahl Harry   Savilahti Erkki  

Scandinavian Journal of Gastroenterology, Vol. 41, Iss. 6, 2006-06 ,pp. : 720-725

Informa Healthcare

Access to resources Recommend Favorite

Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

By  

Digestive Diseases, Vol. 32, Iss. 4, 2014-06 ,pp. : 446-454

Karger

Access to resources Recommend Favorite

Beyond Tumor Necrosis Factor: Next-Generation Biologic Therapy for Inflammatory Bowel Disease

By  

Digestive Diseases, Vol. 27, Iss. 3, 2009-09 ,pp. : 366-369

Karger

Access to resources Recommend Favorite

Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease

By Hindorf U.   Lyrenäs E.   Nilsson Å.   Schmiegelow K.  

Scandinavian Journal of Gastroenterology, Vol. 39, Iss. 11, 2004-11 ,pp. : 1105-1112

Informa Healthcare

Access to resources Recommend Favorite